Stephens Inc’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Stephens Inc’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,615,198	Closed	-$30.5M	–	1238
2019 Q4	$30.5M	Buy	7,615,198 +1,103,763	+17%	+$5.18M	0.64%	21
2019 Q3	$31.9M	Sell	6,511,435 -88,580	-1%	-$496K	0.7%	18
2019 Q2	$40.2M	Buy	6,600,015 +6,182,889	+1,482%	+$32.9M	0.91%	13
2019 Q1	$2.42M	Buy	+417,126	New	+$4.31M	0.06%	353
2018 Q4	–	Sell	-11,784	Closed	-$229K	–	1218
2018 Q3	$229K	Buy	+11,784	New	+$251K	0.01%	1012

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stephens Inc's DPLO Position: Q1 2020 in Review

Stephens Inc sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 7,615,198 shares — an estimated $30.5M sold.

Stephens Inc first reported a position in DPLO in Q3 2018 and held it in 5 quarters. The position peaked at $40.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Stephens Inc reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Stephens Inc sold 7,615,198 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $30.5M.
Stephens Inc first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 5 quarters.
Stephens Inc's DIPLOMAT PHARMACY, INC. position peaked at $40.2M in Q2 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Stephens Inc's 13F filing for Q1 2020, filed 14 May 2020.